Innate lymphoid cells (ILCs) are lymphocytes that do not express the type of diversified antigen receptors expressed on T cells and B cells. ILCs are largely tissue-resident cells and are deeply integrated into the fabric of tissues. The discovery and investigation of ILCs over the past decade has changed our perception of immune regulation and how the immune system contributes to the maintenance of tissue homeostasis. We now know that cytokine-producing ILCs contribute to multiple immune pathways by, for example, sustaining appropriate immune responses to commensals and pathogens at mucosal barriers, potentiating adaptive immunity, and regulating tissue inflammation. Critically, the biology of ILCs also extends beyond classical immunology to metabolic homeostasis, tissue remodeling, and dialog with the nervous system. The last 10 years have also contributed to our greater understanding of the transcriptional networks that regulate lymphocyte commitment and delineation. This, in conjunction with the recent advances in our understanding of the influence of local tissue microenvironments on the plasticity and function of ILCs, has led to a re-evaluation of their existing categorization. In this review, we distill the advances in ILC biology over the past decade to refine the nomenclature of ILCs and highlight the importance of ILCs in tissue homeostasis, morphogenesis, metabolism, repair, and regeneration.
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Innate lymphoid cells (ILCs), which lack adaptive antigen receptors generated by the recombination of genetic elements, are the innate counterparts of T lymphocytes (Spits et al., 2013; Eberl et al., 2015; Artis and Spits, 2015) . ILC1s, ILC2s, and ILC3s mirror CD4 + T helper (Th)1, Th2, and Th17 cells, respectively, in terms of function, whereas natural killer (NK) cells mirror the functions of CD8 + cytotoxic T cells. ILCs and T cells play key roles in orchestrating the most appropriate immune response to the threat faced by the individual. ILC1s and Th1 cells react to intracellular pathogens, such as viruses, and to tumors; ILC2s and Th2 cells respond to large extracellular parasites and allergens; and ILC3s and Th17 cells combat extracellular microbes, such as bacteria and fungi. Myeloid and non-hematopoietic cells instruct the ILCs and T cells, which belong to the lymphoid lineage, about the type of threat they will confront. The ILCs and T cells react by providing positive and negative feedbacks and through immune regulatory and effector functions. This initial description of a simple phenotypic and functional trichotomy has been greatly enriched and has become much more complex since the discovery of these subsets 10 years ago. This review aims to clarify this complexity and to propose an updated and operational classification and nomenclature for ILCs. ILCs act early in the immune response by reacting promptly to signals, or inducer cytokines, expressed by tissue-resident cells.
By contrast, the T cell response takes several days, as these cells must undergo clonal expansion to become operational and develop antigen-specific memory. Nevertheless, several types of T cells are ''pre-programmed'' and function like innate cells in certain tissues. These cells include invariant NKT cells, mucosa-associated invariant T (MAIT) cells, diverse subsets of gd T cells and resident memory T (T RM ) cells selected and expanded during earlier encounters with antigen (Mueller and Mackay, 2016) . A few days after the initiation of an immune reaction, both ILCs and T cells are active, and they cross-regulate each other. ILCs can express major histocompatibility complex (MHC) class II molecules and process antigens, thereby regulating the activity of antigen-specific T cells (Oliphant et al., 2014) . In turn, these T cells produce interleukin-2 (IL-2), promoting ILC activities. Both types of cell generate positive-feedback loops that amplify their responses, but they also compete for the same inducer cytokines and survival factors. Thus, these two types of lymphoid cells mirror one another's activities only partially, thereby ensuring the timely orchestration of the immune response.
ILCs begin functioning during fetal development, as lymphoid tissue-inducer cells (LTi cells) (Mebius et al., 1997) . These cells induce the development of most of the secondary lymphoid organs. They instruct mesenchymal stromal cells to produce the factors required to attract hematopoietic cells to the developing lymphoid structure and retain them there. The interaction between ILCs and the non-hematopoietic microenvironment is an important facet of ILC function maintained from birth into adulthood. It includes the activation of stromal cells for the recruitment, retention, and activation of lymphocytes, and for their regeneration and the activation of defensive and anti-apoptotic programs in epithelial cells. Thus, through their generation early during the formation of the immune system and their prompt reactivity, ILCs play an important role in the crosstalk of lymphoid cells with non-hematopoietic cells and in the spatial organization of immunity.
ILCs are clearly the innate counterpart of T cell effector subsets, but research into ILCs has opened up an unprecedented appreciation of the profound involvement of immune cells in tissue homeostasis, whether morphogenesis, metabolism, regeneration, and growth. ILCs are largely tissue-resident cells and are integrated deep into the fabric of tissues, and studies of these cells have revealed ever more intriguing relationships with basic developmental and biological processes. ILCs play a key role in homeostasis, due to the rapidity with which they react and their presence in normal healthy tissues, including the intestine, lung and adipose tissues, in particular. An absence of ILC3s in the intestine can lead to a loss of control over the symbiotic microbiota. In adipose tissues, ILC2s are involved in thermogenesis in the context of a cold shock. ILCs are also involved in tissue tolerance and regeneration in response to tissue damage. In the intestine and thymus, ILC3s mediate tolerance to chemical toxins and irradiation through the activation of epithelial cells, whereas ILC2s produce amphiregulin (AREG), a member of the EGF family, which is involved in epithelial cell regulation. However, these functions can also favor the development of carcinoma during chronic inflammation and injury, and increase the severity of inflammation induced by pathogens.
The presence of ILCs in non-lymphoid tissues is ensured by the recruitment of ILC progenitors from the blood, and maintained by the expression of local survival factors, such as IL-7. ILCs have slightly different phenotypes in different tissues, and different local microenvironments may induce ILC progenitors from the same subset to adopt tissue-specific expression patterns. Most ILCs are tissue-resident cells (Gasteiger et al., 2015) , but ILC3s can migrate from the intestinal lamina propria to the draining mesenteric lymph node, and NK cells and inflammatory ILC2s circulate in the bloodstream.
We first proposed a common nomenclature for ILCs and ILC subsets in 2013 (Spits et al., 2013) . The use of single-cell RNA sequencing has led to the identification of more than 50 distinct ILC clusters (in t-distributed stochastic neighbor embedding [t-SNE] projection analysis) in different tissues (Gury-BenAri et al., 2016) . We have re-evaluated the original nomenclature, taking into account the identification of ILC developmental lineages, transcriptional networks coordinating ILC effector functions and phenotypes, activation states, and tissue-specific adaptations, and we propose here an updated and comprehensive, but simple and practical, nomenclature for ILCs. We also provide an overview of the newly discovered roles of ILCs in defense, metabolism, repair and interactions with the nervous system.
Nomenclature
The nomenclature for ILCs proposed in 2013 classified these cells into groups 1, 2, and 3, each of which contained one, two or three subsets. The subsets within each group had the same output, including cytokines in particular, and their development and function were dependent on the same transcription factors. Group 1 ILCs comprised NK cells and ILC1s. These cells are dependent on the T-box transcription factor Tbet for their development and function, and they produce interferon-gamma (IFN-g). Group 2 contains a single subset, ILC2s, which are dependent on GATA3 and RORa (Wong et al., 2012) , and produce type 2 cytokines, predominantly IL-5 and IL-13. Group 3 ILCs include natural cytotoxicity receptor (NCR) À ILC3s, NCR + ILC3s, and LTi cells, all of which are dependent on the transcription factor RORgt and can produce IL-17 and/or IL-22. The last decade has provided a wealth of data on the mechanisms of development and the molecules involved in the functions of T helper cell subsets, which has improved our understanding of the development of ILC subsets (Eberl et al., 2015; Artis and Spits, 2015) . Within the three initially proposed ILC groups, we now appreciate the existence of distinct subsets based on developmental trajectories. As such, we now propose to classify ILCs into five subsets-NK cells, ILC1s, ILC2s, ILC3s, and LTi cells-based on their development ( Figure 1 ) and function (Figure 2 ). The ILC nomenclature presented here is approved by the International Union of Immunological Societies (IUIS). NK Cells and ILC1s NK cells are dedicated cytotoxic cells that circulate in the bloodstream (Vivier et al., 2011) . They can kill virus-infected normal and tumor cells. In the mouse thymus, conventional NK cells (cNK) coexist with ILC1s that express CD127 (IL-7Ra) and GATA3, unlike cNK cells, produce IFN-g and granulocytemacrophage colony-stimulating factor (GM-CSF) at much higher levels than cNK cells, and depend on the cytokine IL-7 and the transcription factor GATA3 for their differentiation (Vosshenrich et al., 2006) . ILC1s are generally non-cytotoxic or weakly cytotoxic and function as a first line of defense against infections with viruses and certain bacteria, such as T. gondii (Klose et al., 2014) or C. difficile (Abt et al., 2015) . NK cells and ILC1s have several features in common. Both these cell types produce IFN-g as their principal cytokine output and require Tbet for this function. However, they have different developmental paths ( Figure 1 ). In both humans and in mice, NK cells develop from a common innate lymphoid progenitor (CILP) via an NK cell precursor (NKP), whereas ILC1s develop from CILPs via an innate lymphoid cell precursor (ILCP) (Constantinides et al., 2014; Klose et al., 2014; Lim et al., 2017; Renoux et al., 2015; Scoville et al., 2016) . NK cells and ILC1s are functionally different, as NK cells are dedicated cytotoxic cells strongly expressing perforin, whereas ILC1s have low levels of perforin expression. However, regardless of these developmental and functional differences, the phenotypic characterization of ILC1s is often problematic. ILC1s preferentially express CD49a and TRAIL in both humans and mice, but the specificity of these markers is often lost upon cell activation and is tissue-dependent. ILC1s have some phenotypic markers in common with NK cells and ILC3s, in at least some organs. These markers include NK1.1 in mice, and NCRs, such as NKp44 in humans, and NKp46 in both humans and mice ( (Fuchs et al., 2013) , but the identity of which remains unknown at this time.
shown to distinguish ILC1s from NK cells in mice (Weizman et al., 2017) . Another marker of human NK cells is NKp80, which is not expressed on ILC1s (Freud et al., 2016) . ILC1s are tissue-resident cells, whereas NK cells circulate in the bloodstream (Peng et al., 2013; Gasteiger et al., 2015) . In mice, ILC1s are first detected before birth, whereas NK cells emerge two to three weeks after birth (Diefenbach et al., 2014) . There are also differences in the production of and dependence on transcription factors. In mice, ILC1s are strictly dependent on Tbet, whereas NK cells are present in Tbet-deficient hosts (Daussy et al., 2014) . In addition, NK cells require the T-box factor Eomes, whereas ILC1s can develop in the absence of this transcription factor. Eomes expression is, therefore, often used as a marker for NK cells, although it can be expressed on a proportion of ILC1s. ILC2s ILC2s are defined by their capacity to produce the type 2 cytokines IL-4, IL-5, and IL-13 (Moro et al., 2010; Neill et al., 2010; Price et al., 2010) and are tissue resident (Gasteiger et al., 2015; Moro et al., 2016) . They respond to the cytokines IL-25, TSLP, and IL-33. ILC2s are involved in the innate immune response to parasites, such as the helminth Nippostrongulus brasiliensis. After resolving the infection, ILC2s help to repair damaged tissues by producing AREG (Monticelli et al., 2011 (Monticelli et al., , 2015 . ILC2s contain larger amounts of the transcription factor GATA3 than the other ILC subsets, and absence of GATA3 inhibits the development and function of these cells (Hoyler et al., 2012; Klein Wolterink et al., 2013; Furusawa et al., 2013; Mjö sberg et al., 2012) . Although a classical marker for tissueresident ILC2s in mice is ST2, a component of the IL-33 receptor, some tissue ILC2s do not express ST2 (e.g., skin), as ST2 expression can be impacted by the tissue of origin and the state of the microenvironment. ILC2s present in human peripheral blood lack ST2 (Bal et al., 2016) , but human ILC2s, whether in the peripheral blood or in tissues, selectively express the chemoattractant receptor expressed on Th2 cells (CRTH2) and high levels of CD161 (Mjö sberg et al., 2011) .
ILC3s
ILC3s are abundant at mucosal sites and are involved in the innate immune response to extracellular bacteria and the containment of intestinal commensals (Cella et al., 2009; Luci et al., 2009; Cupedo et al., 2009; Satoh-Takayama et al., 2008; Buonocore et al., 2010; Sonnenberg et al., 2011 Sonnenberg et al., , 2012 Rankin et al., 2016) . The predominant homeostatic cytokine produced by ILC3s is IL-22, by which they maintain intestinal homeostasis and promote the proliferation of intestinal stem cells. In addition, ILC3s can regulate adaptive Th17 cell responses (Hepworth et al., 2013) . In mice, ILC3s are dependent on RORgt for their development and function (Satoh-Takayama et al., 2008; Sanos et al., 2009; Buonocore et al., 2010) , whereas the IL-17A-producing ILC3 subset (but not the IL-22-producing subset) is absent in RORC-deficient humans (Lim et al., 2017) . Two subsets of ILC3 can be distinguished on the basis of the cell surface expression of NKp46 (in mice) and NKp44 (in humans) (Luci et al., 2009; Cupedo et al., 2009; Sanos et al., 2009) , i.e., the NCR + ILC3. Both mouse and human ILC3s can produce GM-CSF. In mice, NKp46 + ILC3s are dependent on Tbet and can produce IFN-g (Sciumé et al., 2012; Klose et al., 2013; Rankin et al., 2013) . These cells develop after birth, following microbial stimulation. Ex-vivo-isolated human ILC3s do not produce IFN-g.
LTi Cells
LTi cells are crucial for the formation of secondary lymph nodes and Peyer's patches during embryonic development, through the action of lymphotoxin (Mebius et al., 1997) . These cells express c-Kit and CCR6, but not NCRs. Like ILC3s, they are strictly dependent on RORgt. LTi cells and postnatal NCR -ILC3s are difficult to separate on the basis of marker expression, but neuropilin (NRP-1), which can be induced on human postnatal NCR À ILC3s may mark the capacity of these cells to mediate the formation of tertiary lymphoid structures (Robinette et al., 2015; Shikhagaie et al., 2017) . However, lymphoid tissue-forming activity is not unique to postnatal ILC3s/LTi cells, as other lymphotoxin-producing cell types may also be involved in this activity. LTi cells and ILC3s have different developmental paths ( Figure 1 ).
ILC Plasticity: A Key to ILC Heterogeneity
There is increasing evidence to suggest that like T helper cell subsets, ILC subsets also display a certain degree of plasticity. (Vonarbourg et al., 2010) .
This process requires a decrease in RORgt expression (Vonarbourg et al., 2010) , with a parallel increase in T-bet (Sciumé et al., 2012; Klose et al., 2013; Rankin et al., 2013) and Notch signaling (Lee et al., 2011; Viant et al., 2016; Chea et al., 2016) . IL-1b, IL-15 and IL-12 are likely the critical factors because human IL-22-producing ILC3s can be converted into IFN-g-producing ILC1-like cells if cultured in vitro with these cytokines (Cella et al., 2010; Bernink et al., 2015) . Recent studies indicate that ILC2s can also convert into IFN-g-producing ILC1s both in vitro and in vivo (Ohne et al., 2016; Bal et al., 2016; Silver et al., 2016) . T-bet and the IL-12 receptor (IL-12R) must be induced for this conversion to occur (Lim et al., 2016) . Furthermore, in vivo exposure of ILC2 to the cytokines IL-25 and IL-33 in mice appear to elicit distinct functional responses. Systemic injections of IL-25 promote the generation of ILC2s, which produce IL-17 in addition to type 2 cytokines and were called inflammatory ILC2s (Huang et al., 2015) . This transformation is dependent on Notch signaling and RORgt expression (Zhang et al., 2017) . IL-25-responding ILC2s arise from resting intestinal ILC2s in response to infection with helminths (Huang et al., 2015; Neill et al., 2010 IL-25-responsive ILC2s circulate in the bloodstream and can migrate to effector sites, where they help to protect tissues following infection (Huang et al., 2015) . It remains unclear whether these ILC2s constitute two different subsets or different activation states of the same plastic cell type. Along this line, a subset of IL-10-producing ILCs has been identified as regulatory ILCs (ILCregs) . These cells are claimed to develop directly from CHILP rather than from ILCp in an ID3-dependent manner and to be distinct from other ILC subsets. As ILC2s can develop into IL-10-producing cells (Gury-BenAri et al., 2016; Seehus et al., 2017) , further investigation is needed to fully understand the nature and potential significance of ILCregs. Finally, human and mouse cytotoxic NK cells also acquire ILC1-like features in response to enhanced TGF-b signaling (Gao et al., 2017; Cortez et al., 2017) .
In addition to cytokine receptors and their downstream transcription factors, ILC plasticity requires defined chromatin regions, such as cis-acting enhancers and silencers of gene expression, to be accessible to transcription factors. Recent studies have investigated chromatin status in human and mouse ILCs, comparing the results obtained to published findings for the CD4 T helper cell counterparts of these cells (Koues et al., 2016; Shih et al., 2016) . Accessible chromatin regions were assessed by ATAC-seq. It was then determined whether these regions were active or simply poised for activation, by assessing histone H3-K27 acetylation or the binding of the regulatory factor p300. One distinctive feature of the ILC regulome is that regulatory regions controlling the expression of signature cytokine genes are already poised or active in ILCs, whereas identical regulatory regions in CD4 T helper cells become accessible only after activation by cytokine signals or infection (Shih et al., 2016) . These results suggest that ILC regulomes are more prone to dynamic changes in response to the microenvironment. Recently it was shown that transition of ILC2s to ILC1s by IL-1b and IL-12 is marked by an atypical chromosomal landscape in which the locus encoding IFN-g and the locus encoding IL-5 and IL-13 are simultaneously accessible (Ohne et al., 2016) .
It is becoming clear that this malleability of ILCs directs the heterogeneity of these cells in the tissues and this may be important for effective immune responses and may also play roles in inflammatory diseases, such as Crohn's disease (Bernink et al., 2015) and chronic obstructive pulmonary disease Bal et al., 2016) . However, the exact functional impact of ILC plasticity is still incompletely understood and remains an active area of research.
ILCs and Metabolism
There is increasing evidence to link ILCs with metabolic homeostasis, dietary stress and obesity. Malnutrition and gluttony can lead to dysregulated ILC-mediated responses both through the availability of specific dietary nutrients, and by altering immune homeostasis as adipose tissue energy stores expand and contract with nutrient availability.
Regulation of ILCs by Dietary Nutrients
The ratios of ILC populations, and their activation states, can be profoundly influenced by the availability of environmental micronutrients and diet-derived metabolites ( Figure 3A) . Signaling via the aryl hydrocarbon receptor (AhR) transcription factor in response to tryptophan metabolites is required to maintain IL-22 expression and intestinal homeostasis (Lee et al., 2011; Kiss et al., 2011) . Consequently, an absence of AhR ligation impairs immunity to intestinal bacterial infections (Lee et al., 2011; Kiss et al., 2011) . Similarly, a deficiency of dietary vitamin A results in abnormally small numbers of ILC3s, a shortfall in IL-22 production and greater susceptibility to gastrointestinal Citrobacter rodentium infection . The vitamin A metabolite retinoic acid (RA), which is produced predominantly by dendritic cells, at least in the intestinal lamina propria, promotes the expression of gut-homing receptors on ILC1s and ILC3s (Kim et al., 2015) , and enhances ILC3 function by upregulating RORgt (van de Pavert et al., 2014) and IL-22 . Conversely, RA suppresses ILC2 proliferation by downregulating IL-7Ra ( Figure 3A) . Accordingly, ILC2 numbers increase during periods of vitamin A deficiency, increasing the efficiency of parasitic helminth expulsion . It has been suggested that during periods of micronutrient scarcity, ILC2s are sustained by fatty-acid metabolism, which maintains the production of IL-13 (Wilhelm et al., 2016) . Thus, host dietary status can substantially modify the balance of the ILC response and alter the predisposition to infection, selectively optimizing immune responses to promote survival during periods of nutrient limitation. There are presumably subtle local adjustments to the balance of available nutrients within tissues, to allow the immune system to respond appropriately to the relentless stream of diverse immune challenges posed by co-infections and the commensal microbiome. A more thorough understanding of these complex processes might facilitate the therapeutic manipulation of immune responses through dietary refinements and nutrient supplementation.
ILCs in Metabolic Tissues
Adipose tissues contain many types of immune cells, which reside among the adipocytes. Recent studies have demonstrated that ILC2s contribute to the maintenance of metabolic homeostasis by supporting the type-2 immune environment characteristic of the adipose tissue of lean individuals. Dysregulation of this pathway leads to obesity with persistent, low-grade type 1 inflammation. ILC2s reside constitutively in visceral adipose tissue (VAT), where they are maintained by the expression of IL-33 (Brestoff et al., 2015) . Here, they produce IL-5 to sustain eosinophils, and IL-13 to polarize M2 macrophages and regulate adiposity and insulin resistance (Brestoff et al., 2015; Molofsky et al., 2013) (Figure 3A ). ILC2s appear to regulate adiposity and caloric expenditure through several different mechanisms. For example, their production of IL-4 and IL-13 is reported to induce pre-adipocyte differentiation into beige adipocytes . Additionally, ILC2s have been shown to express the endopeptidase proprotein convertase subtilisin/ kexin 1 (Pcsk1), which can process the proenkephalin A produced by ILC2s to yield methionine-enkephalin (MetEnk) peptides, which induce UCP1 in adipocytes (Brestoff et al., 2015) . The treatment of mice with exogenous MetEnk induces beiging, thus increasing caloric consumption, although the physiological contribution of ILC2-derived MetEnk remains unclear ( Figure 3A) . Furthermore, in addition to the roles of ILC2s in VAT, IL-33-stimulated ILC2s in the pancreas can drive dendritic cells to secrete retinoic acid, which promotes the secretion of insulin by b cells and glucose regulation (Dalmas et al., 2017) .
During the maintenance of a lean state, heterogeneous ILC1/ NK populations may also be found in the VAT, in which they are thought to help maintain homeostasis. It has been suggested that this may involve the targeted cytotoxic-killing of adipose tissue macrophages, although, counter-intuitively, the targeting of beneficial M2 macrophages has also been reported (Boulenouar et al., 2017) , and modulations in M2 macrophages have not been reported in lean ILC1-deficient mice. With the onset of obesity, there is a shift toward an inflammatory environment in which IFN-g-producing ILC1/NK cells accumulate in the VAT and prime M1 pro-inflammatory macrophage polarization, promoting insulin resistance (Lee et al., 2016; O'Sullivan et al., 2016; Wensveen et al., 2015) (Figure 3A) .
The extent to which ILCs sense and orchestrate changes in the adipose tissues remains unclear, as does the extent to which their activity simply reinforces and stabilizes established immunoregulatory pathways. Nevertheless, ILC subsets clearly help to maintain the delicate immune balance within adipose tissue and are dysregulated in obesity.
ILCs in Tissue Remodeling and Repair
ILCs are largely tissue-resident cells (Gasteiger et al., 2015) . This remarkable tissue dwelling property of ILC provides an interesting framework for understanding the biology of ILCs that seem to fulfill functions in organ homeostasis and repair, not conventionally assigned to the immune system. Tissue residency does not preclude local migration however, and ILC3s have been observed to crawl into and out of cryptopatches at steady state, with increased egress into the tissue during the onset of inflammation (Pearson et al., 2016) . ILCs may follow local chemokine gradients and, in this manner, migrate to local inflammatory foci, returning to newly formed lymphoid structures at the end of an infection. One puzzle has been how the low abundance of ILCs in certain tissues can exert any effect in vivo. Localization and concentration within immune clusters and local migration in response to environmental cues may allow an exponential increase in the potency of ILC-secreted cytokines at sites of tissue damage or infection. In addition to migration within adult tissues, LTi cells, that are required for lymph node and Peyer's patch formation, actively migrate to the lymphoid organ primordia to promote lymphoid tissue development (Veiga-Fernandes et al., 2007) . It is important to note that ILCs are therefore populating organs and tissues often early in ontogeny. LTi cells seed tissues already early during embryonal development (Mebius et al., 1997) . The interdependency of the co-development of organs and components of the innate immune system has not been addressed in much detail and will be an important trajectory for future research. The deep rooting of ILCs in tissues has led to a new appreciation of unsuspected roles of components of the innate immune system in basic developmental and physiological processes such as tissue homeostasis, morphogenesis, growth, and regeneration. On these aspects, ILCs and tissue-resident macrophages might share potential similarities, as they both develop in the mouse, both duringembryonic life and home in tissues where they can proliferate and differentiate into mature effector cells (Bando et al., 2015) .
ILC2s, Tissue Repair, Fibrosis, and Tissue Remodeling for Helminth Expulsion
Type 2 immunity has been largely discussed in the context of immunity to worm infections and of pathogenesis of allergies. It has been proposed that a fundamental property of type 2 immunity is to deal with organisms too large to ingest, break down and digest (Palm et al., 2012) . Therefore, they need to be expelled across barrier surfaces, a process requiring extensive tissue remodeling. Recently a new regulatory loop for ILC2 function has been found that is required to expel worms in process referred to as ''weepand-sweep.'' In the intestine, a secretory lineage of epithelial cells, tuft cells or brush cells, secrete high levels of IL-25 following helminth infection that activates ILC2. ILC2, in turn, secrete IL-13 driving the differentiation of epithelial cells toward the secretory lineage likely by modulating Notch signaling in epithelial cells. Thus, this feedforward loop instructs tissue remodeling required for expulsion of large multicellular pathogens (von Moltke et al., 2016; Howitt et al., 2016; Gerbe et al., 2016) .
Immune activation comes at the price of collateral tissue damage. The best studied example may be influenza infection where most of the clinical sequelae are believed to be a consequence of immune system activation. ILC2s have important roles in limiting tissue damage after infection by the production of ligands for the epithelial growth factor receptor, such as AREG. AREG produced by ILC2s has been shown to control proliferation and differentiation of epithelial cells which was required for epithelial repair following influenza infection (Monticelli et al., 2011; Zaiss et al., 2015) . Similarly, the extensive tissue damages after helminth migration and expulsion also lead to the production of AREG, an important factor for timely repair (Monticelli et al., 2015) ( Figure 3B ). It is possible that the same signaling circuitry and the same cytokines (IL-13 and AREG) that promote tissue repair can become dysregulated in the presence of chronic inflammation and an altered cytokine milieu to promote fibrotic responses, including myofibroblast differentiation, proliferation, and extracellular matrix deposition.
It may be a fundamental property of type 2 immunity and in particular of ILC2s to instruct remodeling of extracellular matrix. Indeed, ILC2s are a relevant source of IL-5 early during immune responses and are indispensable for the recruitment of eosinophils and the programing of alternatively activated macrophages (also referred to as M2 macrophages) . Upon muscle injury, eosinophil-derived IL-4 induces the proliferation of fibro/adipogenic progenitors (FAPs), thereby preventing their differentiation into adipocytes. In this way, FAPs supported myogenesis and the regeneration of skeletal muscle after injury driven by a type 2 immune program (Heredia et al., 2013) . Mechanisms controlling ILC2 activities are also important in regaining homeostasis after inflammation. STAT1 signals downstream of type I and type II interferons and of IL-27 are critical for suppressing ILC2 functions (Duerr et al., 2016; Molofsky et al., 2015; Moro et al., 2016) , whereas STAT5 signals downstream of IL-2, IL-9, and TSLP enhance activation of ILC2, leading to steroid resistance . ILC1s and ILC3s in Repair Type 1 and type 3 responses that are orchestrated by ILC1s and ILC3s, involve phagocytes that release oxygen radicals and enzymes to lethally damage pathogens, kill infected cells, and engulf and digest dying cells and extracellular matrix. Such responses come therefore at a cost for the host's affected tissue, and must be limited in time by repair responses that are coordinated by type 2 responses. Nevertheless, in order to be repaired, a tissue has to be cleansed of microbes, dying cells and debris, and therefore, destructive responses that involve ILC1s and ILC3s are necessary to proceed to repair before the tissue can return to homeostasis ( Figure 3B ).
Paradoxically at first sight, type 3 responses play an important role, not in tissue repair, but in protection from tissue damage. In particular, epithelial barriers are reinforced by type 3 responses in order to resist damage by microbes. IL-22, produced mainly by ILC3s, induces epithelial cells to express anti-bacterial peptides such as Reg3g and Reg3b, as well as antiviral proteins through reinforcement of interferon-l signaling (Herná ndez et al., 2015) . In addition, IL-22 stabilizes the epithelial barrier by protecting epithelial cells and Lgr5 + stem cells from apoptosis induced by irradiation, chemotherapy or graft versus host disease through the activation of STAT3 (Aparicio-Domingo et al., 2015; Lindemans et al., 2015) . IL-22 also protects thymic epithelial cells from irradiation (Dudakov et al., 2012) and hepatocytes from acute inflammation (Zenewicz et al., 2007) ( Figure 3B ). While constitutive absence of IL-22 enhances inflammationdriven colorectal cancer (Huber et al., 2012) , the proliferationpromoting effect of IL-22 on epithelial cells can also sustain the progression of colon cancer (Kirchberger et al., 2013; Hernandez et al., 2018) .
Neuronal Regulation of ILC Responses
The regulation of immune responses has been shown to involve the brain and nervous system. The autonomic nervous system, through its neurotransmitters and neuropeptides, and the hypothalamic-pituitary-adrenal axis work in parallel to modulate inflammation and maintain homeostasis. Recent studies have described a complexity of interactions between ILCs and the nervous system.
Regulation of NK Cells and ILC1s by the HypothalamicPituitary-Adrenal Axis
The neuroendocrine system can sense changes in the environment. It then acts to restore homeostasis by modulating the strength and duration of inflammatory reactions through rapid, pleiotropic mechanisms. Activation of the hypothalamic-pituitary-adrenal axis leads to glucocorticoid release in the blood. NK cells and ILC1s express the glucocorticoid receptor, a transcription factor involved in the regulation of multiple pathways (Quatrini et al., 2017) . Glucocorticoid receptor signaling in these cells inhibits IFN-g production by NK cells in the liver and spleen and by ILC1s in the liver and is required for host resistance to endotoxic shock. This regulation is required for the development of IL-10-dependent endotoxin tolerance. By contrast, disruption of this pathway results in high levels of IFN-g culminating in endotoxin-induced septic shock and death (Quatrini et al., 2017) . During mouse cytomegalovirus infection, regulation of NK cell functions by glucocorticoid receptors is also required for host resistance to infection. This regulation occurs through the tissue-specific expression of PD1, an inhibitory receptor, on spleen NK cells. Binding of PD1 to its ligands downregulates IFN-g production. This inhibition prevents the excessive production that would otherwise result in a lethal IFN-g-dependent spleen immunopathology, without impairing an effective antiviral response (S. Ugolini et al., personal communication) ( Figure 3C ).
Neuropeptides, Neurotransmitters, and ILC2s
Neurotransmitters and neuropeptides play a crucial role in communication between the nervous and immune systems, and many of these molecules are also produced directly by immune cells. The ILCs of the intestine and lungs express receptors for the neurotransmitters and neuropeptides produced in these mucosal tissues. Indeed, various ILC subsets express the b2AR (b2-adrenergic receptor) for epinephrine and norepinephrine, the CHRM (cholinergic receptor muscarinic) for acetylcholine, the VPAC1/2 (vasoactive intestinal peptide receptor) for VIP, the NMUR1 for neuromedin U (NMU) and CALCRL (calcitonin receptor-like) for CGRP. ILC2s are subject to tight regulation by neuropeptides. The principal role of VIP is the maintenance of homeostasis at mucosal barriers through the regulation of IL-5 production . CGRP signaling in ILC2s is required for a full Th2 immune response in models of allergen-induced asthma (Sui et al., 2018) . NMU plays no significant role in homeostatic conditions, but its induction upon helminth infection leads to a type 2 protective immune response in the intestine through intrinsic ILC2 regulation. NMU has also been shown to act in synergy with IL-25 in the induction of cytokine production by lung ILC2s (Cardoso et al., 2017; Klose et al., 2017; Wallrapp et al., 2017 ) ( Figure 3C ). While the role of catecholamines on NK cells appears complex and remains to be dissected in depth, it has been recently demonstrated that b2AR stimulation intrinsically suppresses the proliferation and effector functions of ILC2s. ILC2 responses and type 2 inflammation are, thus, downregulated following exposure to the parasite N. brasiliensis in the gut and by intranasal IL-33 administration or exposure to Alternaria alternata extract in the lungs (Moriyama et al., 2018) ( Figure 3C ). Other interactions between ILC2s and neurons also occur in the mucosal tissues of the respiratory tract. Indeed, ILC2s have been observed very close to SNAP-25 + nerve fibers on lung sections (Wallrapp et al., 2017) , and lung IL-5-producing ILC2s have been identified in collagen-rich regions close to the confluence of medium-sized blood vessels and airways . IL-5-producing ILC2s have also been found close to pulmonary neuroendocrine cells in the airway branch junctions at which particles entering the airways become concentrated (Sui et al., 2018) . Thus, ILC2s appear to be located at strategic points in the mucosal tissues of the airways, acting with the neuroendocrine system to patrol the airways, recruiting circulating immune cells to sites of damage or in response to pathogen invasion. ILC3s and Neuroimmune Cell Units Neuroimmune cell units (NICUs) have recently been described as defined small cellular networks in which immune and neuronal cells are found at the same anatomic site, interact functionally, and participate in tissue homeostasis and integrity (Veiga-Fernandes and Artis, 2018) . The RET neurotrophic factor receptor is a typical example of such communication between the cells of the nervous and immune systems. RET is a receptor tyrosine kinase activated by glial cell-derived neurotrophic factor and related proteins. It plays crucial roles in hematopoiesis, Peyer's patch formation and the development of the gut nervous system (Patel et al., 2012; Veiga-Fernandes et al., 2007) . RET is strongly expressed in the ILC3s of the lamina propria in the adult gut. These cells are located within cryptopatches, close to stellate projections of the lamina propria glial cells. These glial cells are the principal producers of RET ligands, which are induced in response to commensal products and alarmins. This essential glial cell-ILC3 pathway conditions the reactivity of epithelial cells and regulates intestinal defenses against Citrobacter rodentium infection by inducing the production of IL-22 by ILC3s in response to RET ligands (Ibiza et al., 2016) (Figure 3C ). Communications between the central nervous system and the intestine are also mediated by the so-called ''gut-brain axis,'' through projections from the sympathetic and parasympathetic systems, and via the hypothalamic pituitary adrenal axis. The vagus nerve is the principal extrinsic parasympathetic nerve connecting the brainstem and gut. ILC3s are located close to choline acetyltransferase-positive cells in the greater omentum (Dalli et al., 2017) , suggesting that crosstalk between ILC3s and cholinergic vagus nerve fibers occurs not only in the intestine but also in the peritoneum. ILC3s can also be regulated by the cholinergic receptors muscarinic (Chrm)1, 2, 4 and 5, and both mouse and human ILC3s respond to acetyl-chloline stimulation by producing the lipid mediator PCTR1 (16R-glutathionyl, 17S-hydroxy-4Z, 7Z, 10Z, 12E, 14E, 19Z-docosahexaenoic acid) (Dalli et al., 2017) ( Figure 3C ). PCTR1 belongs to a family of proresolving molecules that control the clearance of bacterial infections by phagocytes and attenuate collateral tissue injury and inflammation. Thus, tissue-resident ILC3s actively regulate macrophage and granulocyte responses to infection through the release of cytokines, such as GM-CSF (Mortha et al., 2014) , and by the production of proresolving mediators under vagal system control. The direct role of vagus stimulation in ILC3 control remains to be shown.
Conclusions and Perspectives
After 10 years of intensive research, the field of ILC biology has provided a new vision on the organization of the immune response. Nevertheless, several key questions remain to be addressed.
ILC plasticity may be essential to shape and calibrate ILC responses to different types of pathogenic stimuli. However, several fundamental questions remain to be addressed: (1) When does ILC plasticity arise? Does it occur at all stages of ILC differentiation or is it progressively lost toward the final stages? How to discriminate cell plasticity from various cell activation states? (2) Given that Th cells often display mixed Th1/ Th17 polarization, are there ILCs with a mixed cytokine secretion pattern? (3) What epigenetic circuits are activated and silenced during plastic ILC responses to a changing microenvironment? (4) Is ILC conversion irreversible, or can ILCs repeatedly transform after restimulation with polarizing cytokines? (5) Given that infections, inflammation, and autoimmunity induce the release of inflammatory cytokines into the tissue environment, is ILC conversion enhanced under these conditions? (6) Is this plasticity-the functional capacity of converted ILCs-essential to fight infections and autoimmunity?
Compelling data in human and in the mouse indicate that ILCs are involved in both inflammatory disorders and immunological repair (Ebbo et al., 2017) . The absence of immunodeficiency in ILC-deficient patients in conditions of modern hygiene and medicine led to the proposal that ILCs are dispensable for protective immunity if T and B cell functions are preserved (Vé ly et al., 2016) . Thus, the precise roles of ILCs in immunity and their dialog with the other components of the multilayered immune response await further analysis. Along this line, the role and importance of ILCs in protective immunity in adult humans or wild-type mice, where many tissue-resident adaptive memory cells share space with ILCs, remains to be established. However, the roles of ILCs in adapting tissue physiology to changes in the environment have inspired research into processes that are not conventionally associated with the immune system. Further exploration of these pathways may likely reveal unsuspected pathways by which immune system workings might be harnessed to improve health and health span.
Finally, the role of ILCs in the onset and/or maintenance of inflammation, their preferential homing to mucosal tissues, and the expression of several checkpoint receptors on their surface should encourage researchers to explore the ILCs' manipulation in innovative therapies.
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